Relationship between patent ductus arteriosus and platelet indices in newborn: a systematic review and meta-analysis

Yanbing An1, Gaowa Arigong1, Wuyun Zhao2

  • 1Department of Neonatology, Inner Mongolia Maternal and Child Health Hospital, Hohhot, China.

PubMed

Insights

Newborns with patent ductus arteriosus (PDA) may show lower platelet count and plateletcrit, but higher platelet large cell ratio. These platelet index changes offer insights for early PDA detection and management.

Area of Science:

  • Neonatal Medicine
  • Hematology
  • Pediatric Cardiology

Background:

  • Investigating platelet indices in neonates is crucial for understanding early life health.
  • Patent Ductus Arteriosus (PDA) is a common neonatal condition requiring early diagnosis.
  • The association between platelet parameters and PDA requires further clarification.

Purpose of the Study:

  • To examine the relationship between patent ductus arteriosus (PDA) and various platelet indices in newborns.
  • To synthesize existing evidence on platelet count, plateletcrit, and other platelet markers in neonates with PDA.

Main Methods:

  • A systematic review and meta-analysis were conducted.
  • Searched major Chinese and international databases up to January 31, 2024.
  • Included 32 relevant studies (20 English, 12 Chinese).

Main Results:

  • Neonates with PDA showed significantly lower platelet count (PLT) and plateletcrit (PCT).
  • A higher platelet large cell ratio (P-LCR) was observed in neonates with PDA.
  • Platelet mass, PDW, and MPV did not show significant differences between groups.

Conclusions:

  • Decreased PLT and PCT, along with increased P-LCR, may characterize neonates with PDA.
  • These altered platelet indices could serve as potential biomarkers for early PDA identification and assessment.
  • Understanding these hematological shifts aids in personalized treatment strategies for neonatal PDA.
Abstract